This pamphlet discusses the World Health Organization's Global Plan to Stop Tuberculosis. It provides information about TB infection, explains the global plan, describes the success of the directly observed therapy short course (DOTS) treatment program, and the proposal of the global plan to expand the DOTS program. The pamphlet addresses treatment issues concerning TB-HIV coinfection and drug-resistant TB, the search for new and faster-working drug treatment, and vaccine development and makes a plea for additional funding to help meet the goals of the global plan.

This pamphlet discusses the World Health Organization's Global Plan to Stop Tuberculosis. It provides information about TB infection, explains the global plan, describes the success of the directly observed therapy short course (DOTS)treatment program, and the proposal of the global plan to expand the DOTS program. The pamphlet addresses treatment issues concerning TB-HIV coinfection and drug-resistant TB, the search for new and faster-working drug treatment, and vaccine development and makes a plea for additional funding to help meet the goals of the global plan.

This pamphlet discusses the World Health Organization's Global Plan to Stop Tuberculosis. It provides information about TB infection, explains the global plan, describes the success of the directly observed therapy short course (DOTS) treatment program, and the proposal of the global plan to expand the DOTS program. The pamphlet addresses treatment issues concerning TB-HIV coinfection and drug-resistant TB, the search for new and faster-working drug treatments, and vaccine development and makes a plea for additional funding to help meet the goals of the global plan.

This monograph discusses treatment of sexually transmitted infections (STIs) using recommendations from a meeting of experts convened by the World Health Organization (WHO) in November 2001. The monograph presents the rationale for standard treatment and discusses case management, syndrome management, risk factors for STI-related cervicitis, and drugs used for treating different STIs. It provides information on the treatment of STI-associated syndromes and of specific infections, and explains the considerations behind treatments.

This monograph presents a framework to guide European countries in developing a national plan for reducing TB/HIV. The monograph explains the links between TB and HIV, and outlines the targets, priorities in Europe, strategic components of the plan, and its key operations. The plan is based on strategies used for TB control and HIV/AIDS care and requires collaboration between programs for prevention and control of TB and HIV/AIDS prevention and control programs.

This report discusses the work of the World Health Organization (WHO) in response to HIV/AIDS epidemic. It describes WHO involvement from the beginning, its role as cosponsor of the Joint United Nations Programme on HIV/AIDS and in the new global environment in which countries acknowledged and affirmed the link between health and development and committed themselves to the goal of fighting HIV/AIDS and reversing the epidemic by 2015. It also discusses increased funding by WHO as many countries are looking to WHO for support in building better health systems and services.

This pamphlet advocates integrated management of adolescent/adult illness (IMAI) as the most effective treatment methodology. It presents the rationale for this argument and lists benefits of integrated management, including addresses major adolescent and adult health problems, responds to demand, links HIV care and prevention, improves care for both HIV-positive and HIV-negative adults and adolescents, balances prevention and care, balances attention to acute and chronic care, and addresses special needs of adolescents.

This report presents the case study of the Lighthouse Trust in Malawi, which was established to provide quality care and counseling and to improve the quality of life of persons with HIV/AIDS, including the terminally ill. The report describes the objective of the Lighthouse, its services, management, staffing, funding, community involvement, building facilities, diagnostic services, antiretroviral treatment implementation, clients served, adherence support strategies, clinical outcomes, added improvements, and lessons learned.

This report promotes collaboration between TB and HIV programs in providing a continuum of quality care for people coinfected with TB and HIV/AIDS. It recommends that these activities should be implemented as part of the health sector response to the intersecting TB and HIV epidemics. The report discusses the policy formulation process, the goal and objectives of collaborative TB/HIV activities, and the recommended collaborative TB/HIV activities.

This report presents guidelines for monitoring programs for the prevention of HIV/AIDS in infants and young children. It presents a list of core indicators and additonal indicators for indicating the success of these programs. Countries with prevention programs for infants and young children should have the core indicators in operation. The report gives a definition of each indicator, the rationale for its use, what it measures, measurement tools and how the indicator is measured, and its strengths and limitations.